Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New agents claimed for treatment of psychological disorders

July 31, 2006

New compounds with potential activity in neurological disorders reported

July 31, 2006

New tumor necrosis factor-alpha inhibitors for immunological disorders reported by 4 AZA Bioscience

July 28, 2006

Recent patents impart new therapeutics for cardiovascular disorders

July 28, 2006

Agents for dermatological conditions prepared and tested

July 28, 2006

New agents reported for thrombotic disorders and associated complications

July 27, 2006

Novel prostanoid EP2 agonists for glaucoma emerge from Allergan

July 27, 2006

Recent patents impart new therapeutic agents for cancer

July 27, 2006

Recent GSK patent describes novel diagnostic agents

July 26, 2006

Novel analgesic agents imparted in recent patent literature

July 26, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.